Description: Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Home Page: www.sakarhealthcare.com
406, Silver Oaks Comm. Complex
Ahmedabad,
380007
India
Phone:
91 79 2658 4655
Officers
| Name | Title |
|---|---|
| Mr. Sanjay Surendra Shah | Chairman & MD |
| Mr. Aarsh Sanjay Shah | Joint MD & Exec. Director |
| Ms. Ritaben Sanjay Shah | Whole-Time Director |
| Mr. Dharmesh R. Thaker | Chief Financial Officer |
| Mr. Bharat S. Soni | Company Sec. & Compliance Officer |
Exchange: NSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.2703 |
| Price-to-Book MRQ: | 2.6266 |
| Price-to-Sales TTM: | 3.0626 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 297 |